For Patient Services leaders, the conversation about automation and artificial intelligence is no longer just about technology adoption. It is about operating model design. Programs are being asked to move faster, scale more efficiently, improve the patient and provider experience, and maintain compliance in an environment where complexity continues to grow. In that context, the strategic question is not whether to use automation or AI. It is where each capability creates the greatest value, where it introduces risk, and how both should fit into the broader service model.
Automation as an Operating Discipline
Automation should be viewed less as a point solution and more as a discipline for standardizing work. When a task is rules-based, repeatable, and high volume, automation can create immediate operational leverage by reducing manual effort, improving consistency, and making performance easier to measure. In patient services, that often means applying automation to intake checks, eligibility screening, routing logic, status notifications, and other defined workflows where the desired action is clear.
Strategically, automation is most valuable where variation is unnecessary or harmful. It helps leaders protect quality by ensuring the same rule is applied the same way every time. It also creates a stronger foundation for reporting, forecasting, and accountability because the process is structured and auditable. That reliability matters in patient access, where speed is important, but consistency and control are non-negotiable.
The leadership opportunity is to identify where automation can remove friction without oversimplifying the patient experience. Not every workflow should be automated end to end. The right use cases are those where the decision logic is stable, the compliance requirements are clear, and the handoff to a person is well defined when an exception occurs.
AI as a Strategic Intelligence Layer
AI plays a different role. Where automation executes known rules, AI can help interpret unstructured information, identify patterns, generate content, and support decisions in workflows where variability is unavoidable. That makes AI less of a replacement for automation and more of an intelligence layer that can help programs understand what is happening across large volumes of interactions, documents, and service data.
For example, AI can help summarize patient or provider interactions, classify call topics, surface recurring barriers, support conversational self-service for routine questions, or recommend nextbest actions for review. These capabilities can give leaders better visibility into demand drivers, patient friction points, and emerging service trends. The value is not simply faster task completion; it is better intelligence for improving the program over time.
At the same time, AI requires a different governance posture. Because outputs can vary, leaders need clear guardrails around approved use cases, validation, monitoring, escalation, privacy, and human review. In patient services environments, AI should augment expertise and improve insight, not operate as an unchecked decision-maker.
Choosing the Right Strategic Mix
The strongest patient service programs will not treat automation and AI as competing investments. They will build a portfolio of capabilities matched to the nature of the work. Automation should handle stable, rules-based activity where speed, scale, and consistency matter most. AI should be applied where the work requires interpretation, synthesis, or insight that cannot be captured in a simple script.
A practical decision rule is to start with the problem, not the technology. If the process is predictable, automate it. If the process is variable, information-rich, or insight-dependent, evaluate whether AI can safely improve the workflow. If both are present, design the operating model so automation manages the structured steps and AI enhances the moments where context matters, always with appropriate human oversight.
For Patient Services leaders, the goal is not to appear technologically advanced. The goal is to create a service model that is faster, more resilient, more measurable, and more responsive to patient needs. Automation and AI can both support that goal, but only when each is applied with strategic intent, operational discipline, and a clear understanding of where technology should support, rather than substitute for, human expertise.
About UBC
United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. UBC leads the market in providing integrated, comprehensive clinical, safety, and commercialization services and is uniquely positioned to seamlessly integrate best-in-class services throughout the lifecycle of a product.
About the Author
Dana Edwards, Vice President, Patient Access & Strategic Engagement
Dana Edwards serves as the Vice President, Patient Access & Strategic Engagement at UBC. She brings more than 20 years of experience in executing patient service and market access strategies to this role. Ms. Edwards is a strategic advisor to pharmaceutical and biotech leaders on the design and implementation of patient service programs that synchronize the right people, services, and technology for their unique patient population and therapy.
